US › Healthcare

Scribe Therapeutics Inc. Common Stock (SCTX)

US · Healthcare · Biotechnology

$22.06+5.88%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$2.2M

Net profit

$-17.3M

Net margin

-776.8%

Key statistics

Market cap

$337.2M

Forward P/E

0.0

P/B

0.00

Book value

$-64.31

EPS (TTM)

$-2.21

52-week high

$25.49

52-week low

$15.00

50-day MA

$19.49

200-day MA

$19.49

Shareholding

Insiders

11.46%

Institutions

40.89%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Scribe Therapeutics Inc. Common Stock — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.